Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03890913 · ClinicalTrials.gov registry record
Painted Playgrounds Aim 1
A clinical trial, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- 51
- Enrollment target
NCT03890913: Completed study, sponsored by Pennington Biomedical Research Center.
NCT03890913 is a clinical trial that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 51 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03890913 has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- 51 participants
- Enrollment target
Study Summary
Painted Playgrounds Aim 1: Observation will examine the physical environment of licensed childcare centers before and after painting stencil activities (hopscotch, foursquare, fun trails, etc.) on playgrounds. The stencils are a promising intervention to help decrease obesity and sedentary behaviors in preschool aged children because they are cost-effective and easily scalable. Observations will be held at follow-ups by video recording during recess and using a modified behavioral observation method, called SOPLAY. Surveys will be administered to childcare center directors to report further on their physical activity environment and how much they are interacting with the stencils.
Primary Outcome
The investigators will observe the number of children participating in physical activity during recess before and after the implementation of a playground stenciling intervention to asses for change. The observation will be performed using a modified version of the System for Observing Play and Leisure Activity in Youth (SOPLAY). SOPLAY is an observational tool designed to assess physical activity levels \& environmental conditions in settings where youth are engaged in play and leisure. SOPLAY
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2017-09-01 |
| Est. Completion | 2019-06-30 |
What the finished NCT03890913 record still lists
NCT03890913 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 51 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03890913 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03890913 about?
NCT03890913 is a clinical study titled "Painted Playgrounds Aim 1". Painted Playgrounds Aim 1: Observation will examine the physical environment of licensed childcare centers before and after painting stencil activities (hopscotch, foursquare, fun trails, etc.) on playgrounds. The stencils are a promising intervention to help decrease obesity and sedentary behaviors...
What is the current status of trial NCT03890913?
This trial is currently completed. The enrollment target is 51 participants. The study started on 2017-09-01. Estimated completion is 2019-06-30.
Who is sponsoring clinical trial NCT03890913?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI